DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
10.93
-0.04 (-0.36%)
At close: Aug 26, 2026, 4:00 PM EDT
10.87
-0.06 (-0.55%)
Pre-market: Aug 27, 2026, 8:14 AM EDT
DENTSPLY SIRONA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,643 | 3,680 | 3,793 | 3,965 | 3,922 | 4,231 | |
Revenue Growth | -0.76% | -2.98% | -4.34% | 1.10% | -7.30% | 26.71% |
Cost of Revenue | 1,839 | 1,840 | 1,825 | 1,875 | 1,795 | 1,887 |
Gross Profit | 1,804 | 1,840 | 1,968 | 2,090 | 2,127 | 2,344 |
Selling, General & Admin | 1,461 | 1,445 | 1,581 | 1,617 | 1,596 | 1,547 |
Research & Development | 166 | 150 | 165 | 184 | 174 | 171 |
Operating Expenses | 1,627 | 1,595 | 1,746 | 1,801 | 1,770 | 1,718 |
Operating Income | 177 | 245 | 222 | 289 | 357 | 626 |
Interest Expense | -104 | -102 | -89 | -97 | -76 | -64 |
Interest & Investment Income | 13 | 14 | 20 | 16 | 11 | 3 |
Earnings From Equity Investments | - | - | - | - | -36 | 32 |
Currency Exchange Gain (Loss) | 58 | 32 | 21 | 11 | -6 | 9 |
Other Non Operating Income (Expenses) | 4 | - | -1 | -13 | -4 | -36 |
EBT Excluding Unusual Items | 148 | 189 | 173 | 206 | 246 | 570 |
Merger & Restructuring Charges | -80 | -25 | -95 | -74 | -14 | -28 |
Impairment of Goodwill | -369 | -525 | -773 | -291 | -1,187 | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 3 |
Asset Writedown | -46 | -125 | -241 | -16 | -100 | - |
Pretax Income | -347 | -486 | -936 | -175 | -1,055 | 545 |
Income Tax Expense | 200 | 112 | -26 | -43 | -105 | 134 |
Earnings From Continuing Operations | -547 | -598 | -910 | -132 | -950 | 411 |
Minority Interest in Earnings | 1 | - | - | - | - | - |
Net Income | -546 | -598 | -910 | -132 | -950 | 411 |
Net Income to Common | -546 | -598 | -910 | -132 | -950 | 411 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 200 | 199 | 203 | 212 | 216 | 218 |
Shares Outstanding (Diluted) | 200 | 199 | 203 | 212 | 216 | 220 |
Shares Change | 0.07% | -1.87% | -4.15% | -1.62% | -2.13% | 0.46% |
EPS (Basic) | -2.73 | -3.00 | -4.48 | -0.62 | -4.41 | 1.88 |
EPS (Diluted) | -2.73 | -3.00 | -4.48 | -0.62 | -4.41 | 1.87 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 143 | 104 | 281 | 228 | 368 | 515 |
Free Cash Flow Per Share | 0.72 | 0.52 | 1.38 | 1.07 | 1.71 | 2.34 |
Dividend Per Share | 0.320 | 0.640 | 0.640 | 0.560 | 0.500 | 0.430 |
Dividend Growth | -50.00% | 0% | 14.29% | 12.00% | 16.28% | 7.50% |
Gross Margin | 49.52% | 50.00% | 51.89% | 52.71% | 54.23% | 55.40% |
Operating Margin | 4.86% | 6.66% | 5.85% | 7.29% | 9.10% | 14.80% |
Profit Margin | -14.99% | -16.25% | -23.99% | -3.33% | -24.22% | 9.71% |
Free Cash Flow Margin | 3.92% | 2.83% | 7.41% | 5.75% | 9.38% | 12.17% |
EBITDA | 526 | 597 | 571 | 632 | 685 | 972 |
EBITDA Margin | 14.44% | 16.22% | 15.05% | 15.94% | 17.46% | 22.97% |
D&A For EBITDA | 349 | 352 | 349 | 343 | 328 | 346 |
EBIT | 177 | 245 | 222 | 289 | 357 | 626 |
EBIT Margin | 4.86% | 6.66% | 5.85% | 7.29% | 9.10% | 14.80% |
Effective Tax Rate | - | - | - | - | - | 24.59% |